Rosenberg, TX (November 19, 2025) – OCuSOFT Inc., a privately-held eye and skin care pharma company recognized as developing the first commercial eyelid cleanser, has been named one of the Top 50 Healthcare Technology Companies of 2025 by the Healthcare Technology Report. This year has revealed how quickly healthcare technology can deepen its impact, with notable advances in diagnostics, care delivery, and clinical intelligence.
OCuSOFT Inc. was selected based on nomination submissions as well as further review of its healthcare solution capabilities, company growth and evolution, and management team caliber, among other factors. The Healthcare Technology Report is a leading online resource that provides healthcare executives and key decision makers information related to the best healthcare technology companies and solutions.
Cynthia Barratt, Chief Executive Officer of OCuSOFT® comments “Being named a Top 50 Healthcare Technology Company this year is phenomenal. This is a true honor, and I could not be prouder of our team. As we say here at OCuSOFT®, every day, we play like champions and we finish strong!”
About OCuSOFT Inc.
OCuSOFT Inc. is a privately-held company widely known for its OCuSOFT® Lid Scrub® (OLS) family of eyelid hygiene products. OCuSOFT Inc. offers a complete line of eye care products including not only the OLS hygiene group but also Retaine® MGD® Advanced™, Retaine® CMC®, HypoChlor® Spray, and many others. OCuSOFT Inc. established the Southwest Research & Technology Center which houses numerous eye care related companies including Primera Research Pharma, LLC. Through a licensing agreement, Primera Compounding, LLC developed the first medicated eyelid cleanser containing both OLS coupled with azithromycin, now available through prescription as Biune™ Eyelid Spray.
For more information on OCuSOFT Inc.:
Contact: George Haines, Executive Vice President
Phone: (800) 233-5469
Email: ghaines@ocusoft.com
For more information on Primera Compounding, LLC:
Contact: Patty Heinz, President of Corporate Administration & Compliance
Phone: (800) 233-5469
Email: pheinz@primerarx.com